Loading clinical trials...
Loading clinical trials...
COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients: a Large Study in the Amsterdam MS Cohort
Conditions
Interventions
Testing of SARS-CoV-2 antibodies
Locations
1
Netherlands
VU medical center
Amsterdam, Netherlands
Start Date
August 8, 2020
Primary Completion Date
October 31, 2021
Completion Date
October 31, 2021
Last Updated
January 4, 2023
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
Zoé van Kempen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions